Forte Biosciences (FBRX)

Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

https://www.fortebiorx.com

• YTD Return

  FBRX-34.06%
  S&P 500+24.05%

• 1-Year Return

  FBRX+20.71%
  S&P 500+31.08%

• 3-Year Return

  FBRX-81.18%
  S&P 500+25.95%

• 5-Year Return

  FBRX-93.78%
  S&P 500+89.64%